Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART-19/BCMA for High Risk Multiple Myeloma Followed With Auto-HSCT
NCT03455972Phase 2Active, not recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Feb 2018
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in multiple myeloma (MM), sponsored by First Affiliated Hospital of Soochow University. Primary endpoints: Incidence and severity of adverse events at 2 years, Progression-Free Survival and 2 more. Started Feb 2018; status: active, not recruiting.
02
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03455972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03455972.